| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 227.402 | 257.039 | 265.582 | 464.845 | 409.258 | 430.234 | 350.412 | 331.922 | 326.931 | 299.157 |
| Total Income - EUR | 227.602 | 258.635 | 265.592 | 467.391 | 409.733 | 431.063 | 350.412 | 331.944 | 330.419 | 299.568 |
| Total Expenses - EUR | 226.969 | 252.574 | 246.137 | 405.517 | 383.408 | 353.653 | 306.717 | 307.011 | 311.600 | 288.540 |
| Gross Profit/Loss - EUR | 633 | 6.061 | 19.456 | 61.873 | 26.325 | 77.410 | 43.695 | 24.933 | 18.820 | 11.027 |
| Net Profit/Loss - EUR | 526 | 5.090 | 16.686 | 57.193 | 22.226 | 73.103 | 40.174 | 21.611 | 15.718 | 8.494 |
| Employees | 6 | 5 | 5 | 5 | 5 | 5 | 4 | 3 | 3 | 3 |
Check the financial reports for the company - Farmaplant S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 25.647 | 22.604 | 20.648 | 59.002 | 46.927 | 35.420 | 28.547 | 21.746 | 36.797 | 39.565 |
| Current Assets | 122.561 | 150.654 | 212.570 | 166.333 | 126.218 | 152.986 | 197.086 | 136.437 | 104.293 | 84.952 |
| Inventories | 116.959 | 141.403 | 195.647 | 145.062 | 117.935 | 119.181 | 128.738 | 130.662 | 94.124 | 72.686 |
| Receivables | 4.313 | 5.667 | 10.855 | 7.919 | 3.414 | 7.847 | 5.326 | 4.189 | 4.368 | 727 |
| Cash | 1.289 | 3.584 | 6.068 | 13.351 | 4.869 | 25.958 | 63.022 | 1.586 | 5.801 | 11.539 |
| Shareholders Funds | 8.011 | 13.019 | 29.485 | 86.137 | 91.944 | 78.613 | 117.044 | 27.016 | 21.106 | 13.853 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 140.196 | 160.239 | 203.732 | 139.197 | 81.202 | 109.793 | 108.589 | 131.166 | 120.214 | 111.178 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmaplant S.r.l.